休息状态大脑网络在反向激动剂下对抗大麻素受体1的完全淘汰
ACS chemical neuroscience
|April 4, 2024
概括
长期丧失大麻素受体1 (CB1) 重新连接大脑.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 遗传学 遗传学 是一个
背景情况:
- 大麻素受体1 (CB1) 是THC的关键标,并与各种疾病有关.
- 抑制CB1被用于治疗目的,但其对整个大脑的影响尚未完全理解.
- 以前的研究表明,CB抑制带来了意想不到的心理副作用.
研究的目的:
- 为了研究完整的CB1基因淘汰与短期的CB1抑制对整个大脑的影响.
- 检查缺乏CB1基因 (cnr1) 的小鼠的白质结构和大脑网络活动.
- 为了比较慢性CB1损失与急性抑制使用逆agonistrimonabant的影响.
主要方法:
- 在体内成像测试对 cnr1 淘汰赛小鼠和接受CB1 逆agonist rimonabant治疗的小鼠进行.
- 分析了白质的结构变化.
- 评估了大脑网络活动和功能方向统一性.
主要成果:
- cnr1小鼠表现出改变的白质和功能方向均性 (雄性),网络活动基本不变.
- 里莫纳班特治疗改变了皮质网络活动,但不能改变功能方向均性.
- 里莫纳班没有影响慢性cnr1损失或以前的行为研究影响的大脑区域.
结论:
- 慢性损失的CB1功能导致微妙的大脑重新连接,而在很大程度上保持网络活动.
- 短期的CB1抑制 (rimonabant) 影响网络活动不同于慢性基因淘汰.
- 结果强调了慢性CB1损失和急性抑制之间的显著差异,敦促对CB1向药物进行进一步的临床前研究.
相关概念视频
01:29The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
01:25Drug-Receptor Interaction: Agonist
2.5K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.5K
01:30Spare Receptors
3.6K
Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
3.6K
01:22Opioid Receptors: Overview
776
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
776
01:28Drug-Receptor Interaction: Antagonist
2.9K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.9K
01:29Drug-Receptor Interactions
5.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.2K